The Targeted SMAC Mimetic SW IV-134 is a strong enhancer of standard chemotherapy in pancreatic cancer

Yassar M. Hashim(Cedars-Sinai Medical Center), William G. Hawkins(Washington University in St. Louis)
Journal of Experimental & Clinical Cancer Research
January 17, 2017
10.1186/s13046-016-0470-4
Cited by 15

Related Papers

No related papers found

Powered by citation graph analysis